ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $358,972 | -22.7% | 366,298 | +9.6% | 0.01% | -10.0% |
| Q2 2023 | $464,631 | +10.7% | 334,267 | +26.6% | 0.01% | +11.1% |
| Q1 2023 | $419,906 | -85.6% | 264,092 | -43.5% | 0.01% | -86.8% |
| Q4 2022 | $2,910,874 | +46.0% | 467,235 | +57.0% | 0.07% | +36.0% |
| Q3 2022 | $1,994,000 | +15.5% | 297,658 | +9.6% | 0.05% | +11.1% |
| Q2 2022 | $1,727,000 | +21.5% | 271,543 | +784.5% | 0.04% | -84.7% |
| Q2 2017 | $1,421,000 | – | 30,700 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |